- 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
-
Provided herein are compounds according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, and R7 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) as well as the use of such compounds as M4 receptor agonists.
- -
-
Paragraph 0934-0936
(2021/04/17)
-
- 5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
-
Provided herein are compounds according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, and R7 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) as well as the use of such compounds as M4 receptor agonists.
- -
-
Page/Page column 90-91; 73
(2021/04/17)
-
- CRYSTAL FORM OF TRICYCLIC COMPOUNDS AND APPLICATION THEREOF
-
本發明公開了式(I)所示化合物的A晶型及B晶型,及其在製備治療HBV相關疾病藥物中的應用。 The invention discloses “A”crystal form and“B”crystal form of a compound represented by formula (I) and an application thereof in a preparation of a medicament for treating HBV-related diseases.
- -
-
Paragraph 0039-0040; 0060-0062
(2020/09/18)
-
- SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
-
This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
- -
-
Page/Page column 166; 167
(2010/04/30)
-
- Heterocylic antiviral compounds
-
This invention relates to piperidine derivatives of formula I wherein R1, R2, R3 and R4 are as defined herein useful in the treatment of a variety of disorders, including those in which the modulation of CCR5 re
- -
-
Page/Page column 35
(2008/12/08)
-